复习p53免疫组织化学染色及其在EGFR突变肺腺癌晚期的预后影响
Feng-Che Kuan1,2, Shun-Fu Chang3,4, Yao-Ren Yang2
1Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang-Gung University, Taoyuan 333323, Taiwan.
Cancers
|November 13, 2025
概括
瘤中的高p53蛋白表达与EGFR突变非小细胞肺癌晚期患者的整体生存率更好相关. 这一发现,特别是在具有TP53突变或L858R的患者中,需要在前性试验中进一步调查.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- TP53突变可能会对EGFR突变的高级非小细胞肺癌的预后产生负面影响.
- 了解TP53突变和p53表达的作用对于管理这些患者至关重要.
研究的目的:
- 研究TP53突变和p53蛋白表达在EGFR突变的高级非小细胞肺癌中的临床意义.
- 在这个患者队列中确定p53表达水平的预后值.
主要方法:
- 对83名患有EGFR突变肺腺癌的晚期/转移性肺腺癌患者的回顾性分析,这些患者接受了一线氨酸激酶抑制剂治疗.
- 通过桑格测序检测TP53突变,通过免疫组织化学染色检测p53蛋白表达.
- 卡普兰-梅尔和考克斯的比例危险分析来评估生存结果和危险比率.
主要成果:
- 瘤p53免疫化≥50%与更好的整体存活率 (OS) 有关 (HR:0.49).
- 单独TP53突变并没有与较低的无进展生存期 (PFS) 或OS显著相关.
- 患有EGFR L858R替代和瘤p53免疫染≥50%的患者表现出显著的生存益处 (中位数:20.4个月).
结论:
- 瘤p53免疫染 (≥50%) 作为OS的有利预后标志物,特别是在TP53突变或L858R.患者中.
- 在TP53突变的背景下,p53表达的预后意义需要进一步验证.
- 建议进行前性临床试验,以在基因组时代确认这些发现.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.5K
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
9.2K
相关概念视频
02:23Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
02:38Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K